<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id>
      <journal-id journal-id-type="publisher-id">KJIM</journal-id>
      <journal-title>The Korean Journal of Internal Medicine</journal-title>
      <issn pub-type="ppub">1226-3303</issn>
      <issn pub-type="epub">2005-6648</issn>
      <publisher>
        <publisher-name>The Korean Association of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18309692</article-id>
      <article-id pub-id-type="pmc">2687664</article-id>
      <article-id pub-id-type="doi">10.3904/kjim.2007.22.4.296</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Duodenal Mucosa-Associated Lymphoid Tissue Lymphoma: A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Woo</surname>
            <given-names>Kyung Hee</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Jung Han</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoon</surname>
            <given-names>Seong Bo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jang</surname>
            <given-names>Joo Hyun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Dong Hun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hong</surname>
            <given-names>Seong Ho</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baek</surname>
            <given-names>Il Hyun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Internal Medicine, Kangnam Sacred-heart Hospital, College of Medicine Hallym University, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Correspondence to : Jung Han Kim, M.D., Department of Internal Medicine, Kangnam Sacred-heart Hospital, Hallym University College of Medicine, 948-1, Daelim 1-dong, Youngdeungpo-gu, Seoul 150-950, Korea. Tel: 82-2-829-5414, Fax: 82-2-846-4669, <email>harricil@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>12</month>
        <year>2007</year>
      </pub-date>
      <volume>22</volume>
      <issue>4</issue>
      <fpage>296</fpage>
      <lpage>299</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>4</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>7</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2007 The Korean Association of Internal Medicine</copyright-statement>
        <copyright-year>2007</copyright-year>
      </permissions>
      <abstract>
        <p>Primary duodenal mucosa associated lymphoid tissue (MALT) lymphoma is very rare, and little is known about its clinical course or effective treatment. We describe a case of primary duodenal MALT lymphoma that was resistant to <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) eradication and regressed after chemotherapy with cyclophosphamide, vincristine, and prednisolone (CVP). A 71-year-old woman was referred to our department because of epigastric pain and dyspepsia. Gastroduodenoscopy revealed an irregular mucosal nodular lesion with ulceration extending from the bulb to the second portion of the duodenum. Histopathological examination of a biopsy specimen disclosed low-grade MALT lymphoma composed of atypical lymphoid cells with lymphoepithelial lesion. Abdominal CT scans revealed 0.5 to 1.5 cm lymph nodes in the peritoneal cavity, suggestive of lymph node metastasis. We successfully eradicated <italic>H. pylori</italic> but did not see signs of remission. We administered systemic CVP chemotherapy every 3 weeks. After 6 courses of CVP, the patient achieved complete remission and was followed up without recurrence for about a year.</p>
      </abstract>
      <kwd-group>
        <kwd>MALT lymphoma</kwd>
        <kwd>Duodenum</kwd>
        <kwd>
          <italic>Helicobacter pylori</italic>
        </kwd>
        <kwd>Chemotherapy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Primary lymphomas of the gastrointestinal tract are the most common type of extranodal lymphoma, accounting for less than 12% of all non-Hodgkin's lymphoma (NHL)<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2)</xref>. The majority of these lymphomas arise in the stomach, with less than 30% arising in the small intestine. Among extranodal NHL, mucosa associated lymphoid tissue (MALT)-derived lymphoma (MALT lymphoma) was recognized as a distinct clinicopathological entity in the early 1980s, and can arise in the gastrointestinal tract, lung, eye, salivary gland, and thyroid gland, most frequently in the stomach. Gastric MALT lymphoma is associated with <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) infection, and the eradication of <italic>H. pylori </italic> correlates with tumor regression<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4)</xref>. However, MALT lymphoma of the duodenum is very rare, and little is known about its treatment or clinical course. Although MALT lymphoma regression after <italic>H. pylori</italic> eradication has been sporadically reported<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6)</xref>, duodenal MALT lymphoma may be resistant to <italic>H. pylori</italic> eradication<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8)</xref>. In the current paper, we describe a case of primary duodenal MALT lymphoma that was resistant to <italic>H. pylori</italic> eradication and regressed after chemotherapy with cyclophosphamide, vincristine, and prednisolone (CVP).</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>MATERIALS AND METHODS</title>
      <p>A 71-year-old woman was referred to our hospital because of dyspepsia and epigastric pain during the preceding 3 months. She had no allergies or past medical history, and her family history was unremarkable. The physical examination showed tenderness in the epigastrium but no peripheral lymphadenopathy, hepatosplenomegaly, or intra-abdominal mass. Laboratory examinations revealed normal blood counts and biochemistry and normal serum immunoglobulins. Gastroduodenoscopy revealed irregular nodular mucosal lesions with bleeding ulcerations that extended from the bulb to the second portion of the duodenum (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Histopathological examination of a biopsy specimen showed low-grade MALT lymphoma composed of atypical lymphoid cells with a lymphoepithelial lesion (<xref ref-type="fig" rid="F2">Figure 2</xref>), positive for B-cell surface marker L26 (CD20) and negative for cyclin D1, CD3, and CD45RO. In the stomach, endoscopy and histology showed chronic superficial gastritis associated with <italic>H. pylori</italic> infection. Hospitalization was recommended for staging work-up, but she declined. We decided to eradicate <italic>H. pylori</italic> by treatment with amoxicillin (1000 mg twice daily), pantoprazole (40 mg twice daily), and clarithromycin (50 mg twice daily) for 1 week. Two months after the completion of antibiotic treatment, however, her symptoms were aggravated. Gastroduodenoscopy disclosed no evidence of <italic>H. pylori</italic> in the gastric mucosa, but no sign of regression of the duodenal lesion was observed.</p>
      <p>Thereafter, the patient was admitted for further evaluation and treatment of the duodenal MALT lymphoma. Chest CT scans showed no evidence of lymph node enlargement in the mediastinum. Abdominal CT scans revealed 0.5 to 1.5 cm lymph nodes in the peritoneal cavity, suggestive of lymph node metastasis (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Bone marrow biopsy showed no evidence of lymphoma involvement. The patient was classified as having stage EII2 MALT lymphoma according to the Ann Arbor classification modified by Musshoff<xref ref-type="bibr" rid="B9">9)</xref>. We administered systemic chemotherapy with cyclophosphamide, vincristine, and prednisolone (CVP) every 3 weeks, which was well tolerated except for transient hair loss, and epigastric pain resolved after 2 cycles of chemotherapy. After 6 courses of CVP, the patient achieved complete remission (CR) (<xref ref-type="fig" rid="F1">Figure 1B</xref>, <xref ref-type="fig" rid="F3">3B</xref>) and was followed up without recurrence for about a year.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Gastric MALT lymphoma has been considered to boe preceded by the acquisition of MALT as consequence of <italic>H. pylori</italic> infection. The involvement of <italic>H. pylori</italic> in the pathogenesis of monoclonal lymphoid proliferation may be due to a <italic>H. pylori</italic>-reactive T-cell-mediated reaction<xref ref-type="bibr" rid="B10">10)</xref>. In contrast to gastric MALT lymphoma, the relationship between duodenal MALT lymphoma and <italic>H. pylori</italic> infection has not been established. For duodenal MALT lymphoma, <italic>H. pylori</italic> eradication may<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6)</xref> or may not<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>) lead to lymphoma regression. Here, <italic>H. pylori</italic> eradication did not cure duodenal MALT lymphoma.</p>
      <p>Lepicard et al. reported four cases of duodenal MALT lymphoma treated with oral cyclophophamide (100 mg per day) for 18 months<xref ref-type="bibr" rid="B11">11)</xref>. Tumor infiltration was limited to the duodenal wall in one case and was associated with locoregional lymphadenopathies in three cases. Three patients achieved CR and one achieved partial remission. However, two of the four patients with CR showed relapse microscopically after 2 years. These results suggest that oral cyclophosphamide may be a reasonable treatment option for slowly progressive disease. However, the long-term effects of this treatment strategy and the best approach to relapse remain to be determined. Ochi et al. reported regression of the MALT lymphoma confined from mucosa to submucosa of the duodenum after long-term treatment with clarithromycin<xref ref-type="bibr" rid="B12">12)</xref>, which may have resulted from inhibition of lymphocyte activation. On the other hand, Ventrucci et al. reported a case of primary MALT lymphoma of the papilla of vater that regressed after eight monthly courses of CVP<xref ref-type="bibr" rid="B13">13)</xref>. In our case, <italic>H. pylori</italic> eradication did not lead to lymphoma regression. Abdominal CT scans suggesting involvement of lymph nodes in the peritoneal cavity and the aggravation of symptoms prompted the use of systemic chemotherapy with 6 cycles of CVP, which was well tolerated and led to CR.</p>
      <p>To the best of our knowledge, this is the first case report of a duodenal MALT lymphoma that showed complete remission with CVP chemotherapy. Given the indolent nature of this tumor, monotherapy with cyclophosphamide or clarithromycin may be a reasonable option for MALT lymphoma confined to the mucosa or submucosa of the duodenum. However, systemic chemotherapy may be optimal when there is locoregional lymph node involvement.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radaszkiewicz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dragosics</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bauer</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Gastrointestinal malignant lymphomas of the mucosa-assiciated lymphoid tissue: factors relevant to prognosis</article-title>
          <source>Gastroenterology</source>
          <year>1992</year>
          <volume>102</volume>
          <fpage>1628</fpage>
          <lpage>1638</lpage>
          <pub-id pub-id-type="pmid">1568573</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Najem</surname>
              <given-names>AZ</given-names>
            </name>
            <name>
              <surname>Porcaro</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Rush</surname>
              <given-names>BF</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Primary non-Hodgkin's lymphoma of the duodenum</article-title>
          <source>Cancer</source>
          <year>1984</year>
          <volume>54</volume>
          <fpage>895</fpage>
          <lpage>898</lpage>
          <pub-id pub-id-type="pmid">6547634</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cammarota</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tursi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gasbarrini</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gasbarrini</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Helicobacter pylori eradication and remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma: a long-term follow-up study</article-title>
          <source>J Clin Gastroenterol</source>
          <year>2000</year>
          <volume>31</volume>
          <fpage>169</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="pmid">10993438</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bayerdorffer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Neubauer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rudolph</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Thiede</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lehn</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Eidt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stolte</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Regression of primary gastric lymphoma of the mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection</article-title>
          <source>Lancet</source>
          <year>1995</year>
          <volume>345</volume>
          <fpage>1591</fpage>
          <lpage>1594</lpage>
          <pub-id pub-id-type="pmid">7783535</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagashima</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Maeda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohno</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori</article-title>
          <source>Gastroenterology</source>
          <year>1996</year>
          <volume>111</volume>
          <fpage>1674</fpage>
          <lpage>1678</lpage>
          <pub-id pub-id-type="pmid">8942749</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fischbach</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Tacke</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Greiner</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Konrad</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Muller-Hermelink</surname>
            </name>
          </person-group>
          <article-title>Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori</article-title>
          <source>Lancet</source>
          <year>1997</year>
          <volume>349</volume>
          <fpage>31</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="pmid">8988128</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>Eradication of Helicobacter pylori infection did not lead to cure of duodenal mucosa-associated lymphoid tissue lymphoma</article-title>
          <source>Scand J Gastroenterol</source>
          <year>1999</year>
          <volume>34</volume>
          <fpage>215</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="pmid">10192204</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xiang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Onoda</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ohira</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yukawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Uchida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arakawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wakasa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>KH</given-names>
            </name>
          </person-group>
          <article-title>Mucosa associated lymphoid tissue lymphoma of the duodenum: report of a case resistant to Helicobacter pylori eradication</article-title>
          <source>Hepatogastroenterology</source>
          <year>2004</year>
          <volume>51</volume>
          <fpage>732</fpage>
          <lpage>735</lpage>
          <pub-id pub-id-type="pmid">15143903</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Musshoff</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Klinische stadieneinteilung der nicht Hodgkin lymphoma</article-title>
          <source>Strahlentherapie</source>
          <year>1997</year>
          <volume>153</volume>
          <fpage>218</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="pmid">857349</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hussell</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Isaacson</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Crabtree</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Spencer</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The response of cells from low-grade B-cell gastric lymphomas of mucosaassociated lymphoid tissue to Helicobacter pylori</article-title>
          <source>Lancet</source>
          <year>1993</year>
          <volume>342</volume>
          <fpage>571</fpage>
          <lpage>574</lpage>
          <pub-id pub-id-type="pmid">8102718</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lepicard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lamarque</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Levy</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Copie-Bergman</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Chaumette</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Haioun</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Anglade</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Delchier</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Duodenal mucosa-associated lymphoid tissue lymphoma: treatment with oral cyclophosphamide</article-title>
          <source>Am J Gastroenterol</source>
          <year>2000</year>
          <volume>95</volume>
          <fpage>536</fpage>
          <lpage>539</lpage>
          <pub-id pub-id-type="pmid">10685764</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ochi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tominaga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Okazaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yamamori</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shiba</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fujiwara</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Oshitani</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Higuchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Arakawa</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Regression of primary low-grade mucosa-associated lymphoid tissue lymphoma of duodenum after long-term treatment with clarithromycin</article-title>
          <source>Scand J Gastroenterol</source>
          <year>2006</year>
          <volume>41</volume>
          <fpage>365</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="pmid">16497629</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ventrucci</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gherlinzoni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sabattini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cipolla</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ubalducci</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Pileri</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Primary MALT-lymphoma of the papilla of Vater</article-title>
          <source>Dig Dis Sci</source>
          <year>1998</year>
          <volume>43</volume>
          <fpage>214</fpage>
          <lpage>216</lpage>
          <pub-id pub-id-type="pmid">9508528</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Gastroduodenoscopy. The initial gastroduodenoscopy reveals irregular nodular mucosal lesions with bleeding ulcerations extending form the bulb to the second portion of the duodenum (A). After 6 courses of chemotherapy, the follow-up gastroduodenoscopy shows complete regression of duodenal MALT lymphoma (B).</p>
      </caption>
      <graphic xlink:href="kjim-22-296-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Histological examination of initial biopsy specimens from the duodenal lesion. A. Atypical lymphoid cells invading duodenal mucosa (H&amp;E stain &#xD7;100). B. A lymphoepithelial lesion indicative of MALT lymphoma (H&amp;E stain, &#xD7;200).</p>
      </caption>
      <graphic xlink:href="kjim-22-296-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Abdominal CT scan with contrast. Pre-treatment abdominal CT scan revealed 0.5 to 1.5 cm lymph nodes (arrows) in the peritoneal cavity, suggestive of lymph node metastasis (A, C). After chemotherapy, these enlarged lymph nodes disappeared (B, D).</p>
      </caption>
      <graphic xlink:href="kjim-22-296-g003"/>
    </fig>
  </floats-wrap>
</article>
</pmc-articleset>
